Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Placebo Controlled Trial of SOM230 for the Reduction of Post-Pancreatectomy Fistula, Leak, and Abscess

Phase 3

Completed

Conditions: Pancreatic Cancer

Interventions: Drug: Pasireotide (SOM230)
Other: placebo

First Posted Date: 2009-10-14

Last Posted Date: 2016-02-01

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 439

Registration Number: NCT00994110

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Erlotinib and AT-101 in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients With Epidermal Growth Factor Receptor (EGFR) Activating Mutations

Phase 2

Terminated

Conditions: Lung Cancer

Interventions: Drug: oral erlotinib and pulsed doses of oral AT-101

First Posted Date: 2009-10-02

Last Posted Date: 2015-11-20

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 6

Registration Number: NCT00988169

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine

Phase 2

Completed

Conditions: Aplastic Anemia
Leukemia
Myelodysplastic Syndrome

Interventions: Drug: Busulfan, fludarabine, & cyclophosphamide with immunosuppression with ATG and cyclosporine.
Device: CliniMACS device

First Posted Date: 2009-10-01

Last Posted Date: 2018-07-10

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 45

Registration Number: NCT00987480

Locations: 🇺🇸
The Rockefeller University, New York, New York, United States
🇺🇸
Children's Hospital of Wisconsin, Milwaukee, Wisconsin, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

and more 3 locations

A Pilot Study of Geriatric Specific Interventions for Quality of Life in Elderly Patients With Cancer

Not Applicable

Completed

Conditions: Prostate Cancer
Lymphoma Cancer
Breast Cancer
Gynecological Cancers
Lung Cancer

Interventions: Behavioral: group intervention and questionnaires
Behavioral: individual phone intervention and questionnaires
Behavioral: expressive writing (arm will not be include in the randomization)

First Posted Date: 2009-09-25

Last Posted Date: 2025-02-13

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 107

Registration Number: NCT00984321

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Joan Karnell Cancer Center at Pennsylvania, Philadelphia, Pennsylvania, United States

Serum Estradiol Levels In Postmenopausal Women With Breast Cancer Receiving Adjuvant Aromatase Inhibitors and Vaginal Estrogen

Not Applicable

Completed

Conditions: Atrophic Vaginitis
Breast Cancer

Interventions: Drug: Vagifem® (vaginal 17β-estradiol) questionnaire & menopause symptom checklist

First Posted Date: 2009-09-25

Last Posted Date: 2024-05-14

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 30

Registration Number: NCT00984399

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center@Phelps Memorial Hospital, Sleepy Hollow, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center @ Suffolk, Commack, New York, United States

and more 1 locations

Image-Guided Stereotactic Biopsy of High Grade Gliomas

Not Applicable

Completed

Conditions: Brain Cancer
Glioma

Interventions: Drug: 18F-FLT PET Scan

First Posted Date: 2009-09-18

Last Posted Date: 2020-12-17

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 11

Registration Number: NCT00979810

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Mitomycin C Versus Bacillus Calmette-Guerin in the Intravesical Treatment of Non-Muscle-Invasive Bladder Cancer Patients

Phase 3

Terminated

Conditions: Bladder Cancer

Interventions: Biological: Bacillus Calmette-Guerin (BCG)
Drug: Mitomycin C (MMC)

First Posted Date: 2009-09-10

Last Posted Date: 2015-11-20

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 50

Registration Number: NCT00974818

Locations: 🇺🇸
Weill Medical College of Cornell University, New York, New York, United States
🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Selective Internal Radiation Therapy (SIRT) in Patients With Unresectable Colorectal Cancer Liver Metastases Who Failed Prior Intraarterial Pump Chemotherapy

Phase 1

Completed

Conditions: Rectal Cancer
Colon Cancer

Interventions: Device: SIR-spheres® (Selective Internal Radiation Therapy)

First Posted Date: 2009-09-04

Last Posted Date: 2014-12-11

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 32

Registration Number: NCT00972036

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center 1275 York Avenue, New York, New York, United States

Reacquisition of Radioactive Iodine (RAI) Uptake of RAI-Refractory Metastatic Thyroid Cancers by Pretreatment With the Selective MEK Inhibitor AZD6244

Not Applicable

Completed

Conditions: Thyroid Cancer

Interventions: Biological: AZD6244

First Posted Date: 2009-09-02

Last Posted Date: 2017-04-12

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 24

Registration Number: NCT00970359

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Bevacizumab, Cetuximab, and Cisplatin With IMRT (Intensity-Modulated Radiation Therapy) for Patients With Stage III/IV Head and Neck Squamous Cell Carcinoma

Phase 2

Completed

Conditions: Head and Neck Cancer

Interventions: Other: bevacizumab, cisplatin, cetuximab, radiation therapy

First Posted Date: 2009-08-31

Last Posted Date: 2016-08-10

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 30

Registration Number: NCT00968435

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center at Commack, Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center at Mercy Medical Center, Rockville Centre, New York, United States

and more 2 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy